Why Is Rigel Pharmaceuticals ($RIGL) Stock Down -12.67% Today?
RIGL shares tumbled 12.67% to $39.92 in early trading, extending a post-earnings selloff.
The primary catalyst is a third-quarter earnings miss, with diluted EPS of $0.65 falling short of the roughly $0.87 consensus.
📚 More from Billy’s World
Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y •
YouTube: @BankingWithBilly